PUBLISHER: Renub Research | PRODUCT CODE: 1463187
PUBLISHER: Renub Research | PRODUCT CODE: 1463187
Hormone Replacement Therapy Market, Size, Global Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis
Hormone Replacement Therapy market is projected to attain a value of US$ 35.86 Billion by 2032. In 2023, the worldwide hormone replacement therapy market was appraised to be worth US$ 20.91 Billion, and it increased at a compound annual growth rate of 6.18% from 2024 to 2032.
Global Hormone Replacement Therapy Analysis
Hormone replacement therapy (HRT) uses medications that contain female hormones to replenish the estrogen that the body no longer produces after menopause. HRT can help alleviate menopause symptoms such as hot flashes and night sweats. It can also minimize bone loss and fractures in postmenopausal women. HRT subtypes are based on naturally occurring hormones like progesterone, estrogen, and testosterone. Menopause is a frequently reported consequence of age-related hormonal changes occurring around the age of 50.
The World Population Prospects 2022 report reveals that the global population is expected to increase significantly soon. The United Nations predicts that by 2030, the world's population could reach 8.5 Billion, The world population by 2050 and 2100. Women's bodies are susceptible to hormonal changes, which can cause a various of issues such as weight gain, memory decline, fatigue, low libido, aging appearance, and muscle loss.
The NHSBSA Statistics and Data Science department reported that in 2022-23, 11 million hormone replacement therapy (HRT) items were prescribed in England, an increase of 47% from the previous year. Approximately 2.3 million patients received HRT prescriptions, a 29% increase from the prior year. The report also highlighted that patients in the least deprived areas were prescribed HRT items more than twice as frequently as those in the most deprived areas. Finally, the proportion of HRT prescriptions exempt from prescription charges increased from April 2023, a reversal of the downward trend observed since 2015-16.
Global Hormone Replacement Therapy Trends
Rising R&D and product approvals are expected to aid the growth of the hormonal therapy market. Ascendis Pharma A/S's drug SKYTROFA received market authorization in January 2022 for treating growth hormone disorders in children and adolescents. In November 2021, I-MAB Biopharma Co., Ltd. partnered with Jumpcan Pharmaceutical Group to market and develop eftansomatropin alfa, named TJ101, in China to treat pediatric growth hormone insufficiency.
The rising prevalence of menopausal symptoms and increased awareness of post-menopausal challenges are key drivers advancing the global HRT market. China's economic development and policies have increased women's awareness of self-care and participation in physical examinations. Studies have shown that menopausal symptoms are prevalent in women, with rates as high as 73.8% in community groups and perimenopausal women in rural India being more prone to symptoms compared to pre-menopausal and post-menopausal women.
The prevalence of hormonal imbalances and related disorders is increasing, leading to a rise in demand for hormone replacement therapy. This therapy involves administering synthetic or natural hormones to replace deficient levels of hormones in the body. It is particularly beneficial for individuals experiencing symptoms like hot flashes, mood swings, and reduced libido. The growing awareness of its benefits and the availability of advanced hormone replacement therapies are expected to drive market growth.
United States Hormone Replacement Therapy Market
The US has the biggest market for Hormone Replacement Therapy, with rising utilization among patients over 35 years old. The availability of intensified drugs and an increase in the target population drive market growth. The rise in the release of generic hormone replacement therapy medicines and advances in drug delivery technologies are also contributing factors. NIH reports almost half of post-menopausal US women have used HRT. 1.3 Million American women enter menopause each year. Conjugated equine estrogens/bazedoxifene tablets are available for menopausal VMS treatment and osteoporosis prevention. The American Thyroid Association has predicted that over 12% of the US population will experience a thyroid disorder during their lifetime, affecting almost 20 million Americans every year. This high incidence of thyroid hormone imbalance is expected to boost the studied market in the region. Additionally, in June 2022, Astellas Pharma Inc. submitted a New Drug Application for fezolinetant, seeking approval for the treatment of moderate to severe vasomotor symptoms associated with menopause.
Hormone Replacement Therapy Market Company News
Some of the prominent player in the Hormone Replacement Therapy Market are Abbott Laboratories, Bayer AG, Eli Lilly & Company, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Abbvie Inc. (Allergan plc), Teva Pharmaceutical Industries Ltd, and Dr. Reddy's Laboratories Ltd.
- In February 2023, Korea's Ministry of Food and Drug Safety approved Pfizer's NGENLA for treating growth hormone deficiency.
- Pfizer Inc. finished obtaining Arena Pharmaceuticals in 2022. This acquisition will prompt an upgrade in the portfolio to dermatology, cardiology, gastroenterology, and so forth.
- In February 2022, MHLW of Japan approved NGENLA of Pfizer, Inc., and OPKO, a long-lasting pediatric growth hormone deficiency treatment. This strategic initiative helps companies expand their customer base in different geographies and boost their revenue.
- In June 2022, Halozyme Therapeutics launched TLANDO, an oral treatment to replace endogenous testosterone in adult males with a deficiency or absence.
- In August 2022, Akorn received FDA approval to launch its Generic-Cetrorelix Acetate Injection (0.25 mg). Cetrorelix blocks premature ovulation during ovarian stimulation, making eggs more suitable for fertilization.
Product Type - Global Hormone Replacement Therapy Market breakup in 5 viewpoints:
1. Estrogen Hormone Replacement Therapy
2. Human Growth Hormone Replacement Therapy
3. Thyroid Hormone Replacement Therapy
4. Testosterone Hormone Replacement Therapy
5. Progestogen Hormone Replacement Therapy
Disease Type - Global Hormone Replacement Therapy Market breakup in 5 viewpoints:
1. Menopause
2. Hypothyroidism
3. Male Hypogonadism
4. Growth Hormone Deficiency
5. Others
Route of Administration - Global Hormone Replacement Therapy Market breakup in 3 viewpoints:
1. Oral
2. Parental
3. Others
Distribution Channels - Global Hormone Replacement Therapy Market breakup in 3 viewpoints:
1. Hospitals Pharmacies
2. Retail Pharmacies & Stores
3. Online Pharmacies
Country - Global Hormone Replacement Therapy Market breakup of 25 Countries Covered in the Report:
1. North America
- 1.1 United States
- 1.2 Canada
2. Europe
- 2.1 France
- 2.2 Germany
- 2.3 Italy
- 2.4 Spain
- 2.5 United Kingdom
- 2.6 Belgium
- 2.7 Netherlands
- 2.8 Turkey
3. Asia Pacific
- 3.1 China
- 3.2 Japan
- 3.3 India
- 3.4 South Korea
- 3.5 Thailand
- 3.6 Malaysia
- 3.7 Indonesia
- 3.8 Australia
- 3.9 New Zealand
4. Latin America
- 4.1 Brazil
- 4.2 Mexico
- 4.3 Argentina
5. Middle East & Africa
- 5.1 Saudi Arabia
- 5.2 UAE
- 5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Abbott Laboratories
2. Bayer AG
3. Eli Lilly & Company
4. Novartis AG
5. Novo Nordisk A/S
6. Pfizer Inc.
7. Abbvie Inc. (Allergan plc)
8. Teva Pharmaceutical Industries Ltd
9. Dr. Reddy's Laboratories Ltd
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Global Hormone Replacement Therapy Market
6. Market Share - Global Hormone Replacement Therapy Market
- 6.1 By Therapy Type
- 6.2 By Disease Type
- 6.3 By Route of Administration
- 6.4 By Distribution Channel
- 6.5 By Country
7. Therapy Type - Global Hormone Replacement Therapy Market
- 7.1 Estrogen Hormone Replacement Therapy
- 7.2 Human Growth Hormone Replacement Therapy
- 7.3 Thyroid Hormone Replacement Therapy
- 7.4 Testosterone Hormone Replacement Therapy
- 7.5 Progestogen Hormone Replacement Therapy
8. Disease Type - Global Hormone Replacement Therapy Market
- 8.1 Menopause
- 8.2 Hypothyroidism
- 8.3 Male Hypogonadism
- 8.4 Growth Hormone Deficiency
- 8.5 Others
9. Route of Administration - Global Hormone Replacement Therapy Market
- 9.1 Oral
- 9.2 Parental
- 9.3 Others
10. Distribution Channel - Global Hormone Replacement Therapy Market
- 10.1 Hospitals Pharmacies
- 10.2 Retail Pharmacies & Stores
- 10.3 Online Pharmacies
11. Country - Global Hormone Replacement Therapy Market
- 11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.2 Europe
- 11.2.1 France
- 11.2.2 Germany
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Belgium
- 11.2.7 Netherlands
- 11.2.8 Turkey
- 11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Thailand
- 11.3.6 Malaysia
- 11.3.7 Indonesia
- 11.3.8 Australia
- 11.3.9 New Zealand
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.2 Mexico
- 11.4.3 Argentina
- 11.5 Middle East & Africa
- 11.5.1 Saudi Arabia
- 11.5.2 UAE
- 11.5.3 South Africa
12. Porter's Five Analysis - Global Hormone Replacement Therapy Market
- 12.1 Bargaining Power of Buyers
- 12.2 Bargaining Power of Suppliers
- 12.3 Degree of Rivalry
- 12.4 Threat of New Entrants
- 12.5 Threat of Substitutes
13. SWOT Analysis - Global Hormone Replacement Therapy Market
- 13.1 Strength
- 13.2 Weakness
- 13.3 Opportunity
- 13.4 Threat
14. Company Analysis
- 14.1 Abbott Laboratories
- 14.1.1 Company Overview
- 14.1.2 Product Portfolio
- 14.1.3 Recent Development
- 14.1.4 Financial Performance
- 14.2 Bayer AG
- 14.2.1 Company Overview
- 14.2.2 Product Portfolio
- 14.2.3 Recent Development
- 14.2.4 Financial Performance
- 14.3 Eli Lilly & Company
- 14.3.1 Company Overview
- 14.3.2 Product Portfolio
- 14.3.3 Recent Development
- 14.3.4 Financial Performance
- 14.4 Novartis AG
- 14.4.1 Company Overview
- 14.4.2 Product Portfolio
- 14.4.3 Recent Development
- 14.4.4 Financial Performance
- 14.5 Novo Nordisk A/S
- 14.5.1 Company Overview
- 14.5.2 Product Portfolio
- 14.5.3 Recent Development
- 14.5.4 Financial Performance
- 14.6 Pfizer Inc.
- 14.6.1 Company Overview
- 14.6.2 Product Portfolio
- 14.6.3 Recent Development
- 14.6.4 Financial Performance
- 14.7 Abbvie Inc. (Allergan plc)
- 14.7.1 Company Overview
- 14.7.2 Product Portfolio
- 14.7.3 Recent Development
- 14.7.4 Financial Performance
- 14.8 Teva Pharmaceutical Industries Ltd
- 14.8.1 Company Overview
- 14.8.2 Product Portfolio
- 14.8.3 Recent Development
- 14.8.4 Financial Performance
- 14.9 Dr. Reddy's Laboratories Ltd
- 14.9.1 Company Overview
- 14.9.2 Product Portfolio
- 14.9.3 Recent Development
- 14.9.4 Financial Performance
List of Figures
- Figure-01: Global - Hormone Replacement Therapy Market (Billion US$), 2019 - 2023
- Figure-02: Global - Forecast for Hormone Replacement Therapy Market (Billion US$), 2024 - 2032
- Figure-03: Therapy Type - Estrogen Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-04: Therapy Type - Forecast for Estrogen Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-05: Therapy Type - Human Growth Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-06: Therapy Type - Forecast for Human Growth Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-07: Therapy Type - Thyroid Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-08: Therapy Type - Forecast for Thyroid Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-09: Therapy Type - Testosterone Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-10: Therapy Type - Forecast for Testosterone Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-11: Therapy Type - Progestogen Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-12: Therapy Type - Forecast for Progestogen Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-13: Disease Type - Menopause Market (Million US$), 2019 - 2023
- Figure-14: Disease Type - Forecast for Menopause Market (Million US$), 2024 - 2032
- Figure-15: Disease Type - Hypothyroidism Market (Million US$), 2019 - 2023
- Figure-16: Disease Type - Forecast for Hypothyroidism Market (Million US$), 2024 - 2032
- Figure-17: Disease Type - Male Hypogonadism Market (Million US$), 2019 - 2023
- Figure-18: Disease Type - Forecast for Male Hypogonadism Market (Million US$), 2024 - 2032
- Figure-19: Disease Type - Growth Hormone Deficiency Market (Million US$), 2019 - 2023
- Figure-20: Disease Type - Forecast for Growth Hormone Deficiency Market (Million US$), 2024 - 2032
- Figure-21: Disease Type - Others Market (Million US$), 2019 - 2023
- Figure-22: Disease Type - Forecast for Others Market (Million US$), 2024 - 2032
- Figure-23: Route of Administration - Oral Market (Million US$), 2019 - 2023
- Figure-24: Route of Administration - Forecast for Oral Market (Million US$), 2024 - 2032
- Figure-25: Route of Administration - Parental Market (Million US$), 2019 - 2023
- Figure-26: Route of Administration - Forecast for Parental Market (Million US$), 2024 - 2032
- Figure-27: Route of Administration - Others Market (Million US$), 2019 - 2023
- Figure-28: Route of Administration - Forecast for Others Market (Million US$), 2024 - 2032
- Figure-29: Distribution Channel - Hospitals Pharmacies Market (Million US$), 2019 - 2023
- Figure-30: Distribution Channel - Forecast for Hospitals Pharmacies Market (Million US$), 2024 - 2032
- Figure-31: Distribution Channel - Retail Pharmacies & Stores Market (Million US$), 2019 - 2023
- Figure-32: Distribution Channel - Forecast for Retail Pharmacies & Stores Market (Million US$), 2024 - 2032
- Figure-33: Distribution Channel - Online Pharmacies Market (Million US$), 2019 - 2023
- Figure-34: Distribution Channel - Forecast for Online Pharmacies Market (Million US$), 2024 - 2032
- Figure-35: United States - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-36: United States - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-37: Canada - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-38: Canada - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-39: France - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-40: France - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-41: Germany - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-42: Germany - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-43: Italy - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-44: Italy - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-45: Spain - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-46: Spain - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-47: United Kingdom - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-48: United Kingdom - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-49: Belgium - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-50: Belgium - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-51: Netherlands - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-52: Netherlands - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-53: Turkey - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-54: Turkey - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-55: China - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-56: China - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-57: Japan - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-58: Japan - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-59: India - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-60: India - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-61: South Korea - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-62: South Korea - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-63: Thailand - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-64: Thailand - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-65: Malaysia - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-66: Malaysia - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-67: Indonesia - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-68: Indonesia - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-69: Australia - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-70: Australia - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-71: New Zealand - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-72: New Zealand - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-73: Brazil - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-74: Brazil - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-75: Mexico - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-76: Mexico - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-77: Argentina - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-78: Argentina - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-79: Saudi Arabia - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-80: Saudi Arabia - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-81: UAE - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-82: UAE - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-83: South Africa - Hormone Replacement Therapy Market (Million US$), 2019 - 2023
- Figure-84: South Africa - Forecast for Hormone Replacement Therapy Market (Million US$), 2024 - 2032
- Figure-85: Abbott Laboratories - Global Revenue (Million US$), 2019 - 2023
- Figure-86: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-87: Bayer AG - Global Revenue (Million US$), 2019 - 2023
- Figure-88: Bayer AG - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-89: Eli Lilly & Company - Global Revenue (Million US$), 2019 - 2023
- Figure-90: Eli Lilly & Company - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-91: Novartis AG - Global Revenue (Million US$), 2019 - 2023
- Figure-92: Novartis AG - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-93: Novo Nordisk A/S - Global Revenue (Million US$), 2019 - 2023
- Figure-94: Novo Nordisk A/S - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-95: Pfizer Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-96: Pfizer Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-97: Abbvie Inc. (Allergan plc) - Global Revenue (Million US$), 2019 - 2023
- Figure-98: Abbvie Inc. (Allergan plc) - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-99: Teva Pharmaceutical Industries Ltd - Global Revenue (Million US$), 2019 - 2023
- Figure-100: Teva Pharmaceutical Industries Ltd - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-101: Dr. Reddy's Laboratories Ltd - Global Revenue (Million US$), 2019 - 2023
- Figure-102: Dr. Reddy's Laboratories Ltd - Forecast for Global Revenue (Million US$), 2024 - 2032
List of Tables
- Table-01: Global - Hormone Replacement Therapy Market Share by Therapy Type (Percent), 2019 - 2023
- Table-02: Global - Forecast for Hormone Replacement Therapy Market Share by Therapy Type (Percent), 2024 - 2032
- Table-03: Global - Hormone Replacement Therapy Market Share by Disease Type (Percent), 2019 - 2023
- Table-04: Global - Forecast for Hormone Replacement Therapy Market Share by Disease Type (Percent), 2024 - 2032
- Table-05: Global - Hormone Replacement Therapy Market Share by Route of Administration (Percent), 2019 - 2023
- Table-06: Global - Forecast for Hormone Replacement Therapy Market Share by Route of Administration (Percent), 2024 - 2032
- Table-07: Global - Hormone Replacement Therapy Market Share by Distribution Channel (Percent), 2019 - 2023
- Table-08: Global - Forecast for Hormone Replacement Therapy Market Share by Distribution Channel (Percent), 2024 - 2032
- Table-09: Global - Hormone Replacement Therapy Market Share by Countries (Percent), 2019 - 2023
- Table-10: Global - Forecast for Hormone Replacement Therapy Market Share by Countries (Percent), 2024 - 2032
